Lensar (LNSR) Debt Ratio (2019 - 2026)
Lensar (LNSR) posted quarterly Debt Ratio of 0.08 for Q1 2026, down 87.09% quarter-over-quarter from 0.58 in Q4 2019.
Lensar (LNSR) Debt Ratio (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Debt Ratio for 2 consecutive years, with 0.08 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio changed N/A year-over-year to 0.08; the TTM figure through Mar 2026 stood at 0.08 (changed N/A YoY), while the FY2019 annual figure was 0.58, changed N/A from the prior year.
- Debt Ratio slipped to 0.08 in Q1 2026 per LNSR's latest filing, from 0.58 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.08 in Q1 2026 and bottomed at 0.08 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.18 |
| 10 | Lensar | 103.79 Mn | 90.22 Mn | 9.78 Mn | 0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 0.08 |
| Dec 31, 2019 | 0.58 |